Secondary Research With many years of experience in the healthcare field, we have our own rich proprietary data from various past projects
By leveraging insights and a supportive environment, our consultations enhance the overall efficacy of the weight loss program, leading to better outcomes and a higher likelihood of your long-term health improvement
Low-fat, low-grease days after dose increases
These gastrointestinal issues were generally consistent with the side effect profile seen across incretin-based therapies
Symptoms typically peak during treatment initiation and dose escalation, gradually diminishing over 812 weeks in most patients
The interest has grown intense enough that some doctors have begun prescribing GLP-1 medications off-label, meaning for uses not yet approved by regulators like the FDA, to treat various addictions